419 related articles for article (PubMed ID: 28494183)
1. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
[No Abstract] [Full Text] [Related]
3. Capsaicin topical in emergency department treatment of cannabinoid hyperemesis syndrome.
Waterson Duncan R; Maguire M
Am J Emerg Med; 2017 Dec; 35(12):1977-1978. PubMed ID: 28712644
[No Abstract] [Full Text] [Related]
4. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
Graham J; Barberio M; Wang GS
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
[TBL] [Abstract][Full Text] [Related]
5. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
[TBL] [Abstract][Full Text] [Related]
6. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
[TBL] [Abstract][Full Text] [Related]
7. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
Lee A; Coralic Z
Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
Richards JR; Lapoint JM; Burillo-Putze G
Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
Kum V; Bell A; Fang W; VanWert E
Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
[TBL] [Abstract][Full Text] [Related]
11. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin.
Stumpf JL; Williams LD
J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883
[TBL] [Abstract][Full Text] [Related]
12. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Lee C; Greene SL; Wong A
Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
[No Abstract] [Full Text] [Related]
13. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
Richards JR
J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study.
Yusuf HM; Geier C; Staidle A; Montoy JCC
Am J Emerg Med; 2021 May; 43():142-148. PubMed ID: 33561623
[TBL] [Abstract][Full Text] [Related]
15. TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.
Louis-Gray K; Tupal S; Premkumar LS
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077412
[TBL] [Abstract][Full Text] [Related]
16. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
[TBL] [Abstract][Full Text] [Related]
17. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
Hernandez JM; Paty J; Price IM
CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
Bajgoric S; Samra K; Chandrapalan S; Gautam N
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
